Michelangelo PyML: Introducing Uber’s Platform for Rapid Python ML Model Development

Michelangelo PyML: Introducing Uber’s Platform for Rapid Python ML Model Development

  • October 24, 2018
Table of Contents

Michelangelo PyML: Introducing Uber’s Platform for Rapid Python ML Model Development

As a company heavily invested in AI, Uber aims to leverage machine learning (ML) in product development and the day-to-day management of our business. In pursuit of this goal, our data scientists spend considerable amounts of time prototyping and validating powerful new types of ML models to solve Uber’s most challenging problems (e.g., NLP based smart reply systems, ticket assistance systems, fraud detection, and financial and marketplace forecasting). Once a model type is empirically validated to be best for the task, engineers work closely with data science teams to productionize and make it available for low latency serving at Uber-scale.

This cycle of prototyping, validating, and productionizing is central to ML innovation at Uber, and the less friction at each stage of this process, the faster Uber can innovate.

Source: uber.com

Share :
comments powered by Disqus

Related Posts

The What-If Tool: Code-Free Probing of Machine Learning Models

The What-If Tool: Code-Free Probing of Machine Learning Models

How would changes to a datapoint affect my model’s prediction? Does it perform differently for various groups–for example, historically marginalized people? How diverse is the dataset I am testing my model on?

Read More
AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More
California Law Bans Bots From Pretending to Be Human

California Law Bans Bots From Pretending to Be Human

Are you talking to a real person online or a bot? In California, bots will need to identify themselves thanks to a new bill just signed into law by Gov. Jerry Brown. The measure bans automated accounts from pretending to be real people in order to ‘incentivize a purchase or sale of goods or services in a commercial transaction or to influence a vote in an election,’ effective July 1, 2019.

Read More